Clinical Trial Update: A Double-blind, Parallel Group, Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep [Phase 2]

View source ↗

Summary

Pfizer reports completion of a Phase 2 double-blind, placebo-controlled outpatient trial of PD 00200390 in adults with nonrestorative sleep.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonrestorative Sleep

Drugs mentioned

• PD 00200390

Snippet

Sponsor: Pfizer | Conditions: Nonrestorative Sleep | Phase 2 | Status: COMPLETED